Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-008356
Filing Date
2012-08-14
Accepted
2012-08-14 08:50:01
Documents
14
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clsn_10q-063012.htm 10-Q 932175
2 EXHIBIT 4.1 ex4-1.htm EX-4.1 125101
3 EXHIBIT 4.2 ex4-2.htm EX-4.2 126899
4 EXHIBIT 10.2 ex10-2.htm EX-10.2 355000
5 EXHIBIT 10.3 ex10-3.htm EX-10.3 391647
6 EXHIBIT 31.1 ex31-1.htm EX-31.1 19151
7 EXHIBIT 31.2 ex31-2.htm EX-31.2 18765
8 EXHIBIT 32.1 ex32-1.htm EX-32.1 8650
  Complete submission text file 0001437749-12-008356.txt   7538080

Data Files

Seq Description Document Type Size
9 clsn-20120630.xml EX-101.INS 1282870
10 clsn-20120630.xsd EX-101.SCH 48371
11 clsn-20120630_cal.xml EX-101.CAL 31649
12 clsn-20120630_def.xml EX-101.DEF 237849
13 clsn-20120630_lab.xml EX-101.LAB 308375
14 clsn-20120630_pre.xml EX-101.PRE 243329
Mailing Address 10220 OLD COLUMBIA ROAD SUITE L COLUMBIA MD 21046
Business Address 10220 OLD COLUMBIA ROAD SUITE L COLUMBIA MD 21046-1705 4102905390
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 121029663
SIC: 2834 Pharmaceutical Preparations